products

Bondronat® (ibandronic acid)

Bondronat® (ibandronic acid)

In April 2018, Roche transferred the sponsorship and responsibility for sales and marketing of Bondronat® (ibandronic acid) to Atnahs Pty Limited within Australia. 

For medical and product specific queries relating to Bondronat please contact Medical Information at Clinect, the local designee of Atnahs, on 1800 899 005.

The current Consumer Medicine Information (CMI) and Product Information (PI) for Bondronat are available from the Therapeutic Goods Administration (TGA) website at: http://www.tga.gov.au/about/ebs-picmi.htm.